Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 250 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2422 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

25 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-06-20 2023-11-03 195754
NOVAMOXIN 500MG CAPSULE Resolved 2023-06-20 2023-07-05 195818
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Actual shortage 2023-10-19 2024-03-18 207503
NOVASEN 325MG TABLET (DELAYED-RELEASE) Resolved 2017-04-03 2017-05-23 5165
TEVA-CYPROTERONE / ETHINYL ESTRADIOL 0.035MG 2MG TABLET Resolved 2017-04-25 2017-09-19 8068
NOVO-GESIC 325MG TABLET Resolved 2019-06-27 2020-03-19 87680
NOVO-GESIC 325MG TABLET Resolved 2020-03-26 2020-05-21 109571
NOVO-GESIC 325MG TABLET Resolved 2022-08-18 2022-09-23 167229
NOVO-GESIC FORTE 500MG TABLET Resolved 2020-04-10 2020-06-04 111829
NOVO-HYDROXYZIN 10MG CAPSULE Actual shortage 2017-03-10 2017-10-05 159
NOVO-HYDROXYZIN 25MG CAPSULE Actual shortage 2017-03-13 2017-10-05 1013
NOVO-HYDROXYZIN 50MG CAPSULE Actual shortage 2017-03-13 2020-02-13 1017
TEVA-MYCOPHENOLATE 250MG CAPSULE Resolved 2017-03-14 2017-04-25 2278
NOVO-PROFEN 400MG TABLET Resolved 2018-03-13 2018-05-30 42644
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2020-09-24 2020-10-08 124959
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2021-03-11 2021-04-29 135561
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT Resolved 2022-03-04 2022-03-24 156070
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166975

Showing 461 to 480 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
ACT ETIDROCAL 400MG 500MG TABLET Discontinued 2019-02-21 2019-03-01 76486
TEVA-LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-10-25 2019-10-26 97256
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-01-24 2020-01-24 104277
TEVA-OLMESARTAN 20MG TABLET Discontinued 2020-06-11 2020-06-11 117497
TEVA-OLMESARTAN 40MG TABLET Discontinued 2020-06-11 2020-06-11 117500
TEVA-OLMESARTAN / HCTZ 20MG 12.5MG TABLET Discontinued 2020-06-11 2020-06-11 117513
TEVA-OLMESARTAN / HCTZ 40MG 12.5MG TABLET Discontinued 2020-06-11 2020-06-11 117516
TEVA-OLMESARTAN / HCTZ 40MG 25MG TABLET Discontinued 2020-06-11 2020-06-11 117519
ACT OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63983
ACT OXYCODONE CR 20MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63986
ACT OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63989
ACT OXYCODONE CR 80MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63992
ACT OXYCODONE CR 5MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-22 2018-10-22 65328
ACT RANITIDINE 150MG TABLET Discontinued 2020-05-14 2020-05-14 115079

Showing 21 to 40 of 250